Project Details
Description
Phase 2 Study to Evaluate Dose and Duration of Treatment of Drotrecogin Alfa (Activated)Using Serial Measurements of Protein C in Patients with Severe Sepsis..
| Status | Finished |
|---|---|
| Effective start/end date | 3/13/07 → 9/16/10 |
Funding
- ELI LILLY AND COMPANY
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.